Clinical Trials Browser

Completed × Has announcements × Ovarian Neoplasms × Clear all

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

NCT01968213 2023-06-09

ARIEL3

Phase 3 Completed

564 enrolled 18 charts 2 FDA

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02354586 2022-09-15

QUADRA

Phase 2 Completed

463 enrolled 15 charts 2 FDA

Gynecologic

Ovarian Neoplasms

NCT03180307 2022-02-04

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Phase 3 Completed

140 enrolled 11 charts 2 FDA

Gynecologic

Ovarian Neoplasms

NCT00262847 2019-07-23

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Phase 3 Completed

1,873 enrolled 17 charts 2 FDA

Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Trials

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

ARIEL3

QUADRA

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer